CETP inhibition.
Duriez
Patrick
P
INSERM U545, Lille, France and Laboratory of Physiology, Faculty of Pharmacy, University of Law and Health, 59006 Lille cedex, France. Patrick.Duriez@univ-lille2.fr
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D008076:Cholesterol, HDL / Q000187:drug effects; D008078:Cholesterol, LDL / Q000187:drug effects; D004311:Double-Blind Method; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D011804:Quinolines; C483909:torcetrapib